Back to search

Cardiovascular Effects of Raloxifene Hydrochloride

Data up to Jan 2025

Published2001
Citations48
References107

Total Citations Per Year

Abstract

References (107)

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

1998 • 6,250 citations

Cloning of a novel receptor expressed in rat prostate and ovary.

1996 • 4,782 citations

Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β

1997 • 4,422 citations

Molecular basis of agonism and antagonism in the oestrogen receptor

1997 • 3,285 citations

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women

1995 • 2,281 citations

ERβ: Identification and characterization of a novel human estrogen receptor

1996 • 2,262 citations

Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system

1997 • 2,244 citations

Postmenopausal Estrogen Therapy and Cardiovascular Disease

1991 • 2,008 citations

Regulatory Functions of the Vascular Endothelium

1990 • 1,899 citations

Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

1997 • 1,808 citations

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

1997 • 1,641 citations

Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence

1991 • 1,603 citations

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1995 • 1,532 citations

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1996 • 1,323 citations

Estrogen and Coronary Heart Disease in Women

1991 • 1,237 citations

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.

1990 • 1,066 citations

Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women

1994 • 708 citations

Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women

1998 • 702 citations

Endothelial Dysfunction: Does It Matter? Is It Reversible?

1997 • 680 citations

Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms

1995 • 676 citations

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

1995 • 665 citations

Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription

1994 • 645 citations

The vascular protective effects of estrogen

1996 • 642 citations

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

1994 • 614 citations

Estrogen modulates responses of atherosclerotic coronary arteries.

1990 • 605 citations

Nitric oxide and its role in the cardiovascular system

1995 • 598 citations

Acute vascular effects of estrogen in postmenopausal women.

1994 • 557 citations

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1994 • 543 citations

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1994 • 540 citations

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.

1996 • 505 citations

Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

1995 • 502 citations

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

1994 • 501 citations

Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex

1990 • 486 citations

Estrogen Promotes Angiogenic Activity in Human Umbilical Vein Endothelial Cells In Vitro and in a Murine Model

1995 • 458 citations

Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene

1996 • 432 citations

Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.

1990 • 419 citations

Hormonal Treatment of Postmenopausal Women

1994 • 385 citations

Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women

1997 • 379 citations

A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women

1996 • 362 citations

Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans

1995 • 358 citations

Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.

1987 • 355 citations

Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women

1997 • 353 citations

The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1

2000 • 334 citations

Differential Expression of Estrogen Receptors α and β mRNA During Differentiation of Human Osteoblast SV-HFO Cells

1997 • 306 citations

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

1996 • 285 citations

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1991 • 276 citations

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1995 • 273 citations

Circulating Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted With 17β-Estradiol and Norethisterone Acetate

1995 • 263 citations

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1994 • 261 citations

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

1983 • 244 citations

Endothelial Dysfunction in Atherosclerosis

1996 • 243 citations

Molecular determinants of tissue selectivity in estrogen receptor modulators

1997 • 240 citations

Antioxidant potential of specific estrogens on lipid peroxidation.

1993 • 231 citations

Expression of Estrogen Receptor-β in Human Breast Tumors

1997 • 214 citations

Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens

1995 • 206 citations

Randomized, Double-Blind, Placebo-Controlled Study on Effects of Raloxifene and Hormone Replacement Therapy on Plasma NO Concentrations, Endothelin-1 Levels, and Endothelium-Dependent Vasodilation in Postmenopausal Women

2001 • 183 citations

Phase II Evaluation of Lyl56758 in Metastatic Breast Cancer

1988 • 180 citations

Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys1

1998 • 176 citations

Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene

1997 • 172 citations

Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid

1996 • 172 citations

Raloxifene preserves bone strength and bone mass in ovariectomized rats.

1994 • 165 citations

Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women

1999 • 161 citations

Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function

1998 • 159 citations

Effects of raloxifene hydrochloride on the endometrium of postmenopausal women

1997 • 149 citations

The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial

2000 • 141 citations

Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits

1997 • 135 citations

Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.

1994 • 133 citations

Raloxifene Acutely Relaxes Rabbit Coronary Arteries In Vitro by an Estrogen Receptor–Dependent and Nitric Oxide–Dependent Mechanism

1999 • 133 citations

Postmenopausal hormonal replacement decreases plasma levels of endothelin-1.

1995 • 129 citations

Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.

1990 • 127 citations

Expression of Estrogen Receptor- in Human Breast Tumors

1997 • 127 citations

Estrogen Receptor Ligands Modulate Its Interaction with DNA

1997 • 123 citations

Suppression of spontaneous LH surges in estrogen-treated ovariectomized rats by microimplants of antiestrogens into the preoptic brain

1989 • 120 citations

Antioxidant potential of specific estrogens on lipid peroxidation

1993 • 111 citations

Non-steroidal antioestrogens—Receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells

1984 • 110 citations

Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles1

1998 • 94 citations

Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor

1995 • 88 citations

Alternative mechanisms of action of anti-oestrogens

1994 • 85 citations

Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women

1998 • 84 citations

Effect of 17β-Estradiol on Inhibition of Platelet Aggregation In Vitro Is Mediated by an Increase in NO Synthesis

1998 • 82 citations

Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys

1998 • 80 citations

Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators

1996 • 79 citations

The Role of Endothelin in Coronary Atherosclerosis

1996 • 77 citations

Non-genomic effects of estrogens and antiestrogens

1988 • 70 citations

Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.

1996 • 68 citations

Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.

1996 • 59 citations

Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women

1998 • 55 citations

Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.

1994 • 54 citations

Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity

1997 • 52 citations

Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo

1996 • 50 citations

Raloxifene Lowers Serum Lipoprotein(A) in Healthy Postmenopausal Women

1999 • 48 citations

Endothelial dysfunction in coronary heart disease

1996 • 46 citations

Postmenopausal hormonal replacement decreases plasma levels of endothelin-1

1995 • 46 citations

Clinical Uses of Antiestrogens

1996 • 43 citations

Brzozowski, A M. et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758

1997 • 43 citations

Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles

1998 • 42 citations

Disposition and metabolism of a new benzothiophene antiestrogen in rats, dogs and monkeys

1984 • 42 citations

Antiestrogenic Properties of Raloxifene

1995 • 42 citations

Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions

1994 • 41 citations

Alternate antiestrogens and approaches to the prevention of breast cancer

1995 • 35 citations

Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs

1985 • 33 citations

Inhibitory Actions of Keoxifene on Luteinizing Hormone Secretion in Pituitary Gonadotrophs*

1988 • 29 citations

Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence

1996 • 27 citations

Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women [published erratum appears in J Clin Endocrinol Metab 1997 Jan;82(1):181]

1996 • 18 citations

Effects of Raloxifene in Postmenopausal Women

1998 • 15 citations

Raloxifene, Retinoids, and Lavender: "Me Too" Tamoxifen Alternatives Under Study

1996 • 13 citations

Keoxifene (LY 156758) inhibits follicle-stimulating hormone induced differentiation of cultured rat granulosa cells

1987 • 6 citations

Cited By (0)

Loading...